253 related articles for article (PubMed ID: 36721580)
1. Group A Streptococcus Infections: Their Mechanisms, Epidemiology, and Current Scope of Vaccines.
Iyer V; Sagar V; Toor D; Lyngdoh V; Nongrum G; Kapoor M; Chakraborti A
Cureus; 2022 Dec; 14(12):e33146. PubMed ID: 36721580
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal
Salie T; Engel K; Moloi A; Muhamed B; Dale JB; Engel ME
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669471
[TBL] [Abstract][Full Text] [Related]
3. Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015.
Chochua S; Metcalf BJ; Li Z; Rivers J; Mathis S; Jackson D; Gertz RE; Srinivasan V; Lynfield R; Van Beneden C; McGee L; Beall B
mBio; 2017 Sep; 8(5):. PubMed ID: 28928212
[TBL] [Abstract][Full Text] [Related]
4. Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.
Barth DD; Naicker P; Engel K; Muhamed B; Basera W; Mayosi BM; Dale JB; Engel ME
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666314
[TBL] [Abstract][Full Text] [Related]
5. Variability in the distribution of genes encoding virulence factors and putative extracellular proteins of Streptococcus pyogenes in India, a region with high streptococcal disease burden, and implication for development of a regional multisubunit vaccine.
Sagar V; Bergmann R; Nerlich A; McMillan DJ; Nitsche Schmitz DP; Chhatwal GS
Clin Vaccine Immunol; 2012 Nov; 19(11):1818-25. PubMed ID: 22971782
[TBL] [Abstract][Full Text] [Related]
6. Group A streptococcal vaccines: paving a path for accelerated development.
Dale JB; Fischetti VA; Carapetis JR; Steer AC; Sow S; Kumar R; Mayosi BM; Rubin FA; Mulholland K; Hombach JM; Schödel F; Henao-Restrepo AM
Vaccine; 2013 Apr; 31 Suppl 2():B216-22. PubMed ID: 23598485
[TBL] [Abstract][Full Text] [Related]
7. Group A streptococcal vaccines: facts versus fantasy.
Steer AC; Batzloff MR; Mulholland K; Carapetis JR
Curr Opin Infect Dis; 2009 Dec; 22(6):544-52. PubMed ID: 19797947
[TBL] [Abstract][Full Text] [Related]
8.
Wang J; Ma C; Li M; Gao X; Wu H; Dong W; Wei L
Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766186
[No Abstract] [Full Text] [Related]
9. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of group A streptococcus isolates recovered from the north-west of Pretoria, South Africa.
Khosa XV; Kgasha O; Mabuza H; Moshe M; Engel K; Nchabeleng M
S Afr Med J; 2021 Apr; 111(5):487-490. PubMed ID: 34852893
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Global Collection of Group A
Frost HR; Davies MR; Delforge V; Lakhloufi D; Sanderson-Smith M; Srinivasan V; Steer AC; Walker MJ; Beall B; Botteaux A; Smeesters PR
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915226
[TBL] [Abstract][Full Text] [Related]
13. Accelerating the development of a group A Streptococcus vaccine: an urgent public health need.
Excler JL; Kim JH
Clin Exp Vaccine Res; 2016 Jul; 5(2):101-7. PubMed ID: 27489799
[TBL] [Abstract][Full Text] [Related]
14. High diversity of group A streptococcal emm types among healthy schoolchildren in Ethiopia.
Abdissa A; Asrat D; Kronvall G; Shittu B; Achiko D; Zeidan M; Yamuah LK; Aseffa A
Clin Infect Dis; 2006 May; 42(10):1362-7. PubMed ID: 16619146
[TBL] [Abstract][Full Text] [Related]
15. Decoding the molecular epidemiology of group A streptococcus - an Indian perspective.
Abraham T; Sistla S
J Med Microbiol; 2019 Jul; 68(7):1059-1071. PubMed ID: 31192782
[TBL] [Abstract][Full Text] [Related]
16. Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.
Good MF; Pandey M; Batzloff MR; Tyrrell GJ
Expert Rev Vaccines; 2015; 14(11):1459-70. PubMed ID: 26485214
[TBL] [Abstract][Full Text] [Related]
17. Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
Dale JB; Penfound TA; Tamboura B; Sow SO; Nataro JP; Tapia M; Kotloff KL
Vaccine; 2013 Mar; 31(12):1576-81. PubMed ID: 23375817
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes.
Burlet E; HogenEsch H; Dunham A; Morefield G
AAPS J; 2017 May; 19(3):875-881. PubMed ID: 28283948
[TBL] [Abstract][Full Text] [Related]
19. Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop.
Moreland NJ; Waddington CS; Williamson DA; Sriskandan S; Smeesters PR; Proft T; Steer AC; Walker MJ; Baker EN; Baker MG; Lennon D; Dunbar R; Carapetis J; Fraser JD
Vaccine; 2014 Jun; 32(30):3713-20. PubMed ID: 24837510
[TBL] [Abstract][Full Text] [Related]
20. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.
Rivera-Hernandez T; Pandey M; Henningham A; Cole J; Choudhury B; Cork AJ; Gillen CM; Ghaffar KA; West NP; Silvestri G; Good MF; Moyle PM; Toth I; Nizet V; Batzloff MR; Walker MJ
mBio; 2016 Jun; 7(3):. PubMed ID: 27302756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
